Health Canada, Novavax
FDA approves updated Novavax COVID vaccine amid summer surge
The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the vaccine “more closely targets” variants circulating nationwide,
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...
available at www.sec.gov and www.novavax.com, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this ...
For Novavax, it is three weeks after the last dose and for the ... of locations nationwide," President and Chief Executive Officer John C. Jacobs said in a news release.
Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) ...
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...
GAITHERSBURG, Md., Sept. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the ...
For Novavax, it is three weeks after the last ... President and Chief Executive Officer John C. Jacobs said in a news release. The FDA says vaccines will need to be assessed annually, like for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback